Predicting trough levels in patients receiving infliximab maintenance therapy using interval (non-trough) serum infliximab levels

Predicting trough levels in patients receiving infliximab maintenance therapy using interval (non-trough) serum infliximab levels - PREDIX

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41068

Enrollment

Registered

2014-06-30

Start date

2014-07-22

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease enteritis regionalis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age *18 years - Crohn*s disease based on endoscopy and pathology - Clinical remission based on a Harvey Bradshaw Index score of

Exclusion criteria

Exclusion criteria: - Change in immunomodulator co-treatment within the previous 3 months - Previous non-adherence to the 8-week infusion schedule

Design outcomes

Primary

Measure	Time frame
Serum infliximab level at week 0, 4, 6 and 8.	—

Secondary

Measure	Time frame
CRP, albumin	—

Countries

Netherlands

Outcome results